{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T04:08:48Z","timestamp":1782187728762,"version":"3.54.5"},"reference-count":104,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,1,18]],"date-time":"2022-01-18T00:00:00Z","timestamp":1642464000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100011110","name":"UCB","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100011110","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Best Practice &amp; Research Clinical Endocrinology &amp; Metabolism"],"published-print":{"date-parts":[[2022,3]]},"DOI":"10.1016\/j.beem.2022.101614","type":"journal-article","created":{"date-parts":[[2022,1,21]],"date-time":"2022-01-21T11:21:55Z","timestamp":1642764115000},"page":"101614","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["Regulation of bone mass in endocrine diseases including diabetes"],"prefix":"10.1016","volume":"36","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0917-9743","authenticated-orcid":false,"given":"Claire","family":"Higham","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2730-6080","authenticated-orcid":false,"given":"Bo","family":"Abrahamsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.beem.2022.101614_bib1","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1038\/nrendo.2015.89","article-title":"Skeletal changes through the lifespan\u2014from growth to senescence","volume":"11","author":"Farr","year":"2015","journal-title":"Nat Rev Endocrinol"},{"key":"10.1016\/j.beem.2022.101614_bib2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fendo.2017.00252","article-title":"Expanding the role of thyroid-stimulating hormone in skeletal physiology","volume":"8","author":"Baliram","year":"2017","journal-title":"Front Endocrinol"},{"key":"10.1016\/j.beem.2022.101614_bib3","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/s40618-017-0753-4","article-title":"Thyroid diseases and bone health","volume":"41","author":"Williams","year":"2018","journal-title":"J\u00a0Endocrinol Invest"},{"key":"10.1016\/j.beem.2022.101614_bib4","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1111\/j.0954-6820.1978.tb08406.x","article-title":"A\u00a0tetracycline-based histomorphometric evaluation of bone resorption and bone turnover in hyperthyroidism and hyperparathyroidism","volume":"204","author":"Mosekilde","year":"1978","journal-title":"Acta Med Scand"},{"key":"10.1016\/j.beem.2022.101614_bib5","first-page":"796871","article-title":"Bone indices in thyroidectomized patients on long-term substitution therapy with levothyroxine assessed by DXA and HR-pQCT","volume":"2015","author":"Moser","year":"2015","journal-title":"J\u00a0Thyroid Res"},{"key":"10.1016\/j.beem.2022.101614_bib6","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1002\/jbmr.2416","article-title":"The excess risk of major osteoporotic fractures in hypothyroidism is driven by cumulative hyperthyroid as opposed to hypothyroid time: an observational register-based time-resolved cohort analysis","volume":"30","author":"Abrahamsen","year":"2015","journal-title":"J\u00a0Bone Miner Res"},{"key":"10.1016\/j.beem.2022.101614_bib7","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1111\/joim.12688","article-title":"Association between subclinical thyroid dysfunction and change in bone mineral density in prospective cohorts","volume":"283","author":"Segna","year":"2018","journal-title":"J\u00a0Intern Med"},{"key":"10.1016\/j.beem.2022.101614_bib8","doi-asserted-by":"crossref","first-page":"e043007","DOI":"10.1136\/bmjopen-2020-043007","article-title":"Effects of thyroid-stimulating hormone suppression after thyroidectomy for thyroid cancer on bone mineral density in postmenopausal women: a systematic review and meta-analysis","volume":"11","author":"Kwak","year":"2021","journal-title":"BMJ Open"},{"key":"10.1016\/j.beem.2022.101614_bib9","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1089\/thy.2020.0084","article-title":"Consequences of hyperthyroidism and its treatment for bone microarchitecture assessed by high-resolution peripheral quantitative computed tomography","volume":"31","author":"Nicolaisen","year":"2021","journal-title":"Thyroid"},{"key":"10.1016\/j.beem.2022.101614_bib10","doi-asserted-by":"crossref","first-page":"2040","DOI":"10.1002\/jbmr.2244","article-title":"Low serum thyrotropin level and duration of suppression as a predictor of major osteoporotic fractures - the OPENTHYRO register cohort","volume":"29","author":"Abrahamsen","year":"2014","journal-title":"J\u00a0Bone Miner Res"},{"key":"10.1016\/j.beem.2022.101614_bib11","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/S0167-4943(97)00013-7","article-title":"Use of disphosphonates in the treatment of osteoporosis in thyroidectomized patients on levothyroxin replacement therapy","volume":"25","author":"Panebianco","year":"1997","journal-title":"Arch Gerontol Geriatr"},{"key":"10.1016\/j.beem.2022.101614_bib12","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1089\/thy.2008.0428","article-title":"Osteoporosis and thyrotropin-suppressive therapy: reduced effectiveness of alendronate","volume":"19","author":"Panico","year":"2009","journal-title":"Thyroid : Official Journal of the American Thyroid Association"},{"key":"10.1016\/j.beem.2022.101614_bib13","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1007\/s00268-002-6589-9","article-title":"Fractures in patients with primary hyperparathyroidism: nationwide follow-up study of 1201 patients","volume":"27","author":"Vestergaard","year":"2003","journal-title":"World J Surg"},{"key":"10.1016\/j.beem.2022.101614_bib14","doi-asserted-by":"crossref","first-page":"3213","DOI":"10.1210\/jc.2013-1518","article-title":"Bone mineral density evolution after successful parathyroidectomy in patients with normocalcemic primary hyperparathyroidism","volume":"98","author":"Koumakis","year":"2013","journal-title":"J\u00a0Clin Endocrinol Metabol"},{"key":"10.1016\/j.beem.2022.101614_bib15","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1007\/s40618-020-01447-7","article-title":"Efficacy of parathyroidectomy compared with active surveillance in patients with mild asymptomatic primary hyperparathyroidism: a systematic review and meta-analysis of randomized-controlled studies","volume":"44","author":"Anagnostis","year":"2021","journal-title":"J\u00a0Endocrinol Invest"},{"key":"10.1016\/j.beem.2022.101614_bib16","doi-asserted-by":"crossref","first-page":"1907","DOI":"10.1002\/jbmr.3177","article-title":"Effect of surgery versus observation: skeletal 5-year outcomes in a randomized trial of patients with primary HPT (the SIPH study)","volume":"32","author":"Lundstam","year":"2017","journal-title":"J\u00a0Bone Miner Res : The Official Journal of the American Society for Bone and Mineral Research"},{"key":"10.1016\/j.beem.2022.101614_bib17","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1007\/s00198-016-3750-0","article-title":"Bone imaging in hypoparathyroidism","volume":"28","author":"Silva","year":"2017","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.beem.2022.101614_bib18","doi-asserted-by":"crossref","first-page":"1738","DOI":"10.1002\/jbmr.2501","article-title":"The epidemiology of nonsurgical hypoparathyroidism in Denmark: a nationwide case finding study","volume":"30","author":"Underbjerg","year":"2015","journal-title":"J\u00a0Bone Miner Res"},{"key":"10.1016\/j.beem.2022.101614_bib19","article-title":"Loss of insulin receptor in osteoprogenitor cells impairs structural strength of bone","volume":"2014","author":"Thrailkill","year":"2014","journal-title":"J\u00a0Diabetes Res"},{"key":"10.1016\/j.beem.2022.101614_bib20","doi-asserted-by":"crossref","first-page":"R137","DOI":"10.1530\/EJE-16-0652","article-title":"Diabetes mellitus, a state of low bone turnover-a systematic review and meta-analysis","volume":"176","author":"Hygum","year":"2017","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.beem.2022.101614_bib21","doi-asserted-by":"crossref","first-page":"2363","DOI":"10.1002\/jbmr.4140","article-title":"Bone turnover markers do not predict fracture risk in type 2 diabetes","volume":"35","author":"Napoli","year":"2020","journal-title":"J\u00a0Bone Miner Res"},{"key":"10.1016\/j.beem.2022.101614_bib22","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1111\/pedi.12987","article-title":"Decreased markers of bone turnover in children and adolescents with type 1 diabetes","volume":"21","author":"Madsen","year":"2020","journal-title":"Pediatr Diabetes"},{"key":"10.1016\/j.beem.2022.101614_bib23","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1007\/s00592-017-0973-2","article-title":"Bone health in subjects with type 1 diabetes for more than 50 years","volume":"54","author":"Maddaloni","year":"2017","journal-title":"Acta Diabetol"},{"key":"10.1016\/j.beem.2022.101614_bib24","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fendo.2020.578194","article-title":"Dual effects of lipid metabolism on osteoblast function","volume":"11","author":"Alekos","year":"2020","journal-title":"Front Endocrinol"},{"key":"10.1016\/j.beem.2022.101614_bib25","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1007\/s00125-005-1786-3","article-title":"Relative fracture risk in patients with diabetes mellitus, and the impact of insulin and oral antidiabetic medication on relative fracture risk","volume":"48","author":"Vestergaard","year":"2005","journal-title":"Diabetologia"},{"key":"10.1016\/j.beem.2022.101614_bib26","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1093\/aje\/kwm106","article-title":"Systematic review of type 1 and type 2 diabetes mellitus and risk of fracture","volume":"166","author":"Janghorbani","year":"2007","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.beem.2022.101614_bib27","doi-asserted-by":"crossref","first-page":"2585","DOI":"10.1007\/s00198-018-4650-2","article-title":"Diagnosis and management of bone fragility in diabetes: an emerging challenge","volume":"29","author":"Ferrari","year":"2018","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.beem.2022.101614_bib28","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1007\/BF02556109","article-title":"Diabetic bone disease","volume":"49","author":"Bouillon","year":"1991","journal-title":"Calcif Tissue Int"},{"key":"10.1016\/j.beem.2022.101614_bib29","doi-asserted-by":"crossref","first-page":"115932","DOI":"10.1016\/j.bone.2021.115932","article-title":"Effect of peripheral neuropathy on bone mineral density in adults with diabetes: a systematic review of the literature and meta-analysis","volume":"147","author":"Mohseni","year":"2021","journal-title":"Bone"},{"key":"10.1016\/j.beem.2022.101614_bib30","first-page":"996","article-title":"The impact of antiosteoporotic drugs on glucose metabolism and fracture risk in diabetes: good or bad news?","volume":"10","author":"Anastasilakis","year":"2021","journal-title":"J\u00a0Clin Med"},{"key":"10.1016\/j.beem.2022.101614_bib31","doi-asserted-by":"crossref","first-page":"R137","DOI":"10.1530\/EJE-16-0652","article-title":"Diabetes mellitus, a state of low bone turnover-a systematic review and meta-analysis","volume":"176","author":"Hygum","year":"2017","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.beem.2022.101614_bib32","doi-asserted-by":"crossref","first-page":"2210","DOI":"10.1016\/j.numecd.2021.04.014","article-title":"Management of bone fragility in type 2 diabetes: perspective from an interdisciplinary expert panel","volume":"31","author":"Chiodini","year":"2021","journal-title":"Nutr Metabol Cardiovasc Dis"},{"key":"10.1016\/j.beem.2022.101614_bib33","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1056\/NEJMoa1708322","article-title":"Romosozumab or alendronate for fracture prevention in women with osteoporosis","volume":"377","author":"Saag","year":"2017","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.beem.2022.101614_bib34","article-title":"Alliances of the gut and bone axis","author":"Hansen","year":"2021","journal-title":"Semin Cell Dev Biol"},{"key":"10.1016\/j.beem.2022.101614_bib35","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1038\/s41574-019-0246-y","article-title":"The role of osteoblasts in energy homeostasis","volume":"15","author":"Dirckx","year":"2019","journal-title":"Nat Rev Endocrinol"},{"key":"10.1016\/j.beem.2022.101614_bib36","doi-asserted-by":"crossref","first-page":"R119","DOI":"10.1530\/EJE-20-0548","article-title":"Bone complications of bariatric surgery: updates on sleeve gastrectomy, fractures, and interventions","volume":"183","author":"Beavers","year":"2020","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.beem.2022.101614_bib37","doi-asserted-by":"crossref","first-page":"2953","DOI":"10.1210\/jc.2019-00008","article-title":"Separate and combined effects of GIP and GLP-1 infusions on bone metabolism in overweight men without diabetes","volume":"104","author":"Bergmann","year":"2019","journal-title":"J\u00a0Clin Endocrinol Metabol"},{"key":"10.1016\/j.beem.2022.101614_bib38","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1007\/s00198-003-1454-8","article-title":"A\u00a0theoretical analysis of the relative influences of peak BMD, age-related bone loss and menopause on the development of osteoporosis","volume":"14","author":"Hernandez","year":"2003","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.beem.2022.101614_bib39","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1016\/j.bone.2011.02.010","article-title":"Effect of maturational timing on bone mineral content accrual from childhood to adulthood: evidence from 15years of longitudinal data","volume":"48","author":"Jackowski","year":"2011","journal-title":"Bone"},{"key":"10.1016\/j.beem.2022.101614_bib40","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1111\/j.1365-2265.2012.04418.x","article-title":"The effect of gonadotrophin-releasing hormone agonist treatment over 3 years on bone mineral density and body composition in girls with central precocious puberty","volume":"77","author":"Park","year":"2012","journal-title":"Clin Endocrinol"},{"key":"10.1016\/j.beem.2022.101614_bib41","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1002\/jbmr.534","article-title":"Bone mineral density loss in relation to the final menstrual period in a multiethnic cohort: results from the Study of Women's Health across the Nation (SWAN)","volume":"27","author":"Greendale","year":"2012","journal-title":"J\u00a0Bone Miner Res : The Official Journal of the American Society for Bone and Mineral Research"},{"key":"10.1016\/j.beem.2022.101614_bib42","article-title":"Interaction between bone and immune cells: implications for postmenopausal osteoporosis","volume":"S1084-9521(21)00123-3","author":"Fischer","year":"2021","journal-title":"Semin Cell Dev Biol"},{"key":"10.1016\/j.beem.2022.101614_bib43","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/j.cell.2007.07.025","article-title":"Estrogen prevents bone loss via estrogen receptor \u03b1 and induction of fas ligand in osteoclasts","volume":"130","author":"Nakamura","year":"2007","journal-title":"Cell"},{"key":"10.1016\/j.beem.2022.101614_bib44","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/8756-3282(87)90004-4","article-title":"Age-related changes in iliac crest trabecular microanatomic bone structure in man","volume":"8","author":"Compston","year":"1987","journal-title":"Bone"},{"key":"10.1016\/j.beem.2022.101614_bib45","doi-asserted-by":"crossref","first-page":"E249","DOI":"10.1210\/jc.2012-3406","article-title":"Effects of estrogen with micronized progesterone on cortical and trabecular bone mass and microstructure in recently postmenopausal women","volume":"98","author":"Farr","year":"2013","journal-title":"J\u00a0Clin Endocrinol Metabol"},{"key":"10.1016\/j.beem.2022.101614_bib46","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1002\/jbmr.3641","article-title":"Change in bone density and reduction in fracture risk: a meta-regression of published trials","volume":"34","author":"Bouxsein","year":"2019","journal-title":"J\u00a0Bone Miner Res"},{"key":"10.1016\/j.beem.2022.101614_bib47","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1359\/jbmr.060312","article-title":"Effects of conjugated equine estrogen on risk of fractures and BMD in postmenopausal women with hysterectomy: results from the women's health initiative randomized trial","volume":"21","author":"Jackson","year":"2006","journal-title":"J\u00a0Bone Miner Res"},{"key":"10.1016\/j.beem.2022.101614_bib48","first-page":"794","article-title":"The timing hypothesis: do coronary risks of menopausal hormone therapy vary by age or time since menopause onset? Metabolism","volume":"65","author":"Bassuk","year":"2016","journal-title":"Clin Exp"},{"key":"10.1016\/j.beem.2022.101614_bib49","first-page":"380","article-title":"The effects of transdermal estrogen delivery on bone mineral density in postmenopausal women: a meta-analysis","volume":"16","author":"Abdi","year":"2017","journal-title":"Iran J Pharm Res (IJPR)"},{"key":"10.1016\/j.beem.2022.101614_bib50","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1359\/jbmr.2002.17.1.1","article-title":"Relationships between bone mineral density and incident vertebral fracture risk with raloxifene therapy","volume":"17","author":"Sarkar","year":"2002","journal-title":"J\u00a0Bone Miner Res"},{"key":"10.1016\/j.beem.2022.101614_bib51","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1002\/jbmr.3622","article-title":"One year of romosozumab followed by two years of denosumab maintains fracture risk reductions: results of the FRAME extension study","volume":"34","author":"Lewiecki","year":"2019","journal-title":"J\u00a0Bone Miner Res"},{"key":"10.1016\/j.beem.2022.101614_bib52","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1210\/clinem\/dgz196","article-title":"Sex-specific estrogen levels and reference intervals from infancy to late adulthood determined by LC-MS\/MS","volume":"105","author":"Frederiksen","year":"2020","journal-title":"J\u00a0Clin Endocrinol Metabol"},{"key":"10.1016\/j.beem.2022.101614_bib53","doi-asserted-by":"crossref","first-page":"2412","DOI":"10.1210\/jc.2018-02047","article-title":"Serum sex hormones and the risk of fracture across the menopausal transition: study of women's health across the nation","volume":"104","author":"Cauley","year":"2019","journal-title":"J\u00a0Clin Endocrinol Metabol"},{"key":"10.1016\/j.beem.2022.101614_bib54","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S1470-2045(07)70003-7","article-title":"Skeletal effects of exemestane on bone-mineral density, bone biomarkers, and fracture incidence in postmenopausal women with early breast cancer participating in the Intergroup Exemestane Study (IES): a randomised controlled study","volume":"8","author":"Coleman","year":"2007","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.beem.2022.101614_bib55","doi-asserted-by":"crossref","first-page":"1802","DOI":"10.1210\/jc.2011-3045","article-title":"Osteoporosis in men: an Endocrine Society clinical practice guideline","volume":"97","author":"Watts","year":"2012","journal-title":"J\u00a0Clin Endocrinol Metabol"},{"key":"10.1016\/j.beem.2022.101614_bib56","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1016\/j.annonc.2020.07.019","article-title":"Bone health in cancer: ESMO clinical practice guidelines \u2020","volume":"31","author":"Coleman","year":"2020","journal-title":"Ann Oncol"},{"key":"10.1016\/j.beem.2022.101614_bib57","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1172\/JCI84137","article-title":"Gonadal steroid-dependent effects on bone turnover and bone mineral density in men","volume":"126","author":"Finkelstein","year":"2016","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.beem.2022.101614_bib58","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1002\/jbmr.2485","article-title":"The effects of androgens on murine cortical bone do not require AR or ER\u03b1 signaling in osteoblasts and osteoclasts","volume":"30","author":"Ucer","year":"2015","journal-title":"J\u00a0Bone Miner Res"},{"key":"10.1016\/j.beem.2022.101614_bib59","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1359\/jbmr.071212","article-title":"Regulation of bone turnover by sex steroids in men","volume":"23","author":"Sanyal","year":"2008","journal-title":"J\u00a0Bone Miner Res"},{"key":"10.1016\/j.beem.2022.101614_bib60","doi-asserted-by":"crossref","first-page":"4785","DOI":"10.1210\/jc.2009-0739","article-title":"Effects of aromatase inhibition on bone mineral density and bone turnover in older men with low testosterone levels","volume":"94","author":"Burnett-Bowie","year":"2009","journal-title":"J\u00a0Clin Endocrinol Metabol"},{"key":"10.1016\/j.beem.2022.101614_bib61","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1002\/(SICI)1097-4644(199702)64:2<295::AID-JCB12>3.0.CO;2-I","article-title":"Osteogenic differentiation of purified, culture-expanded human mesenchymal stem cells in\u00a0vitro","volume":"64","author":"Jaiswal","year":"1997","journal-title":"J\u00a0Cell Biochem"},{"key":"10.1016\/j.beem.2022.101614_bib62","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/j.cmet.2010.05.005","article-title":"Glucocorticoids suppress bone formation by attenuating osteoblast differentiation via the monomeric glucocorticoid receptor","volume":"11","author":"Rauch","year":"2010","journal-title":"Cell Metabol"},{"key":"10.1016\/j.beem.2022.101614_bib63","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1210\/er.2012-1050","article-title":"11\u03b2-Hydroxysteroid dehydrogenase 1: translational and therapeutic aspects","volume":"34","author":"Gathercole","year":"2013","journal-title":"Endocr Rev"},{"key":"10.1016\/j.beem.2022.101614_bib64","first-page":"751","article-title":"Effects of the circadian variation in serum cortisol on markers of bone turnover and calcium homeostasis in normal postmenopausal women","volume":"83","author":"Heshmati","year":"1998","journal-title":"J\u00a0Clin Endocrinol Metabol"},{"key":"10.1016\/j.beem.2022.101614_bib65","doi-asserted-by":"crossref","first-page":"E293","DOI":"10.1210\/jc.2013-1418","article-title":"Genetic polymorphisms in 11\u03b2-hydroxysteroid dehydrogenase type 1 correlate with the postdexamethasone cortisol levels and bone mineral density in patients evaluated for osteoporosis","volume":"99","author":"Siggelkow","year":"2014","journal-title":"J\u00a0Clin Endocrinol Metabol"},{"key":"10.1016\/j.beem.2022.101614_bib66","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1172\/JCI2799","article-title":"Inhibition of osteoblastogenesis and promotion of apoptosis of osteoblasts end osteocytes by glucocorticoids potential mechanisms of their deleterious effects on bone","volume":"102","author":"Weinstein","year":"1998","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.beem.2022.101614_bib67","first-page":"3366","article-title":"Glucocorticoid dose determines osteocyte cell fate","volume":"25","author":"Jia","year":"2011","journal-title":"FASEB (Fed Am Soc Exp Biol) J : Official Publication of the Federation of American Societies for Experimental Biology"},{"key":"10.1016\/j.beem.2022.101614_bib68","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1677\/joe.0.1540397","article-title":"Glucocorticoids inhibit bone resorption by isolated rat osteoclasts by enhancing apoptosis","volume":"154","author":"Dempster","year":"1997","journal-title":"J\u00a0Endocrinol"},{"key":"10.1016\/j.beem.2022.101614_bib69","doi-asserted-by":"crossref","first-page":"229","DOI":"10.7326\/0003-4819-129-3-199808010-00012","article-title":"Interactions between the hypothalamic-pituitary-adrenal axis and the female reproductive system: clinical implications","volume":"129","author":"Chrousos","year":"1998","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.beem.2022.101614_bib70","first-page":"381","article-title":"Effects of glucocorticoids on calcium and phosphate excretion","volume":"171","author":"Ritz","year":"1984","journal-title":"Adv Exp Med Biol"},{"key":"10.1016\/j.beem.2022.101614_bib71","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1210\/er.2018-00097","article-title":"Glucocorticoids and bone: consequences of endogenous and exogenous excess and replacement therapy","volume":"39","author":"Hardy","year":"2018","journal-title":"Endocr Rev"},{"key":"10.1016\/j.beem.2022.101614_bib72","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1007\/s11657-015-0244-1","article-title":"The risk factors for fractures and trabecular bone-score value in patients with endogenous Cushing's syndrome","volume":"10","author":"Belaya","year":"2015","journal-title":"Arch Osteoporos"},{"key":"10.1016\/j.beem.2022.101614_bib73","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1530\/eje.0.1460051","article-title":"Increased risk of osteoporotic fractures in patients with Cushing's syndrome","volume":"146","author":"Vestergaard","year":"2002","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.beem.2022.101614_bib74","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1210\/jc.2005-0582","article-title":"Bone demineralization and vertebral fractures in endogenous cortisol excess: role of disease etiology and gonadal status","volume":"91","author":"Tauchmanov\u00e0","year":"2006","journal-title":"J\u00a0Clin Endocrinol Metabol"},{"key":"10.1016\/j.beem.2022.101614_bib75","doi-asserted-by":"crossref","DOI":"10.1210\/clinem\/dgaa263","article-title":"Bone evaluation by high-resolution peripheral quantitative computed tomography in patients with adrenal incidentaloma","volume":"105","author":"Moraes","year":"2020","journal-title":"J\u00a0Clin Endocrinol Metabol"},{"key":"10.1016\/j.beem.2022.101614_bib76","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1007\/s00198-007-0514-x","article-title":"Skeletal differences in bone mineral area and content before and after cure of endogenous Cushing's syndrome","volume":"19","author":"F\u00fcto","year":"2008","journal-title":"Osteoporos Int : A Journal Established as Result of Cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA"},{"key":"10.1016\/j.beem.2022.101614_bib77","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1093\/qjmed\/93.2.105","article-title":"Use of oral corticosteroids in the United Kingdom","volume":"93","author":"van Staa","year":"2000","journal-title":"QJM : Monthly Journal of the Association of Physicians"},{"key":"10.1016\/j.beem.2022.101614_bib78","doi-asserted-by":"crossref","first-page":"1982","DOI":"10.1093\/rheumatology\/ker017","article-title":"Prevalence of long-term oral glucocorticoid prescriptions in the UK over the past 20 years","volume":"50","author":"Fardet","year":"2011","journal-title":"Rheumatology"},{"key":"10.1016\/j.beem.2022.101614_bib79","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1007\/s00198-014-2883-2","article-title":"International management of bone health in glucocorticoid-exposed individuals in the observational GLOW study","volume":"26","author":"Silverman","year":"2015","journal-title":"Osteoporos Int : A Journal Established as Result of Cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA"},{"key":"10.1016\/j.beem.2022.101614_bib80","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1164\/rccm.2110047","article-title":"The impact of oral corticosteroid use on bone mineral density and vertebral fracture","volume":"166","author":"Walsh","year":"2002","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.beem.2022.101614_bib81","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1359\/JBMR.040134","article-title":"A\u00a0meta-analysis of prior corticosteroid use and fracture risk","volume":"19","author":"Kanis","year":"2004","journal-title":"J\u00a0Bone Miner Res : The Official Journal of the American Society for Bone and Mineral Research"},{"key":"10.1016\/j.beem.2022.101614_bib82","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1007\/s001980200108","article-title":"The epidemiology of corticosteroid-induced osteoporosis: a meta-analysis","volume":"13","author":"van Staa","year":"2002","journal-title":"Osteoporos Int : A Journal Established as Result of Cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA"},{"key":"10.1016\/j.beem.2022.101614_bib83","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1007\/s002230001146","article-title":"Effects of risedronate treatment on bone density and vertebral fracture in patients on corticosteroid therapy","volume":"67","author":"Wallach","year":"2000","journal-title":"Calcif Tissue Int"},{"key":"10.1016\/j.beem.2022.101614_bib84","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1001\/jama.2017.8040","article-title":"Association between alendronate use and hip fracture risk in older patients using oral prednisolone","volume":"318","author":"Axelsson","year":"2017","journal-title":"JAMA"},{"key":"10.1016\/j.beem.2022.101614_bib85","first-page":"91","article-title":"Growth hormone and bone","volume":"5","author":"Eriksen","year":"1992","journal-title":"J\u00a0Pediatr Endocrinol"},{"key":"10.1016\/j.beem.2022.101614_bib86","first-page":"1344","article-title":"Increased bone density after recombinant human growth hormone (GH) therapy in adults with isolated GH deficiency","volume":"76","author":"O\u2019halloran","year":"1993","journal-title":"J\u00a0Clin Endocrinol Metabol"},{"key":"10.1016\/j.beem.2022.101614_bib87","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1210\/jc.2011-0179","article-title":"Evaluation and treatment of adult growth hormone deficiency: an Endocrine Society clinical practice guideline","volume":"96","author":"Molitch","year":"2011","journal-title":"J\u00a0Clin Endocrinol Metabol"},{"key":"10.1016\/j.beem.2022.101614_bib88","first-page":"82","article-title":"Adult growth hormone (GH)-Deficient patients demonstrate heterogeneity between childhood onset and adult onset before and during human GH treatment 1","volume":"82","author":"Attanasio","year":"1997","journal-title":"J\u00a0Clin Endocrinol Metabol"},{"key":"10.1016\/j.beem.2022.101614_bib89","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1210\/jc.2003-030685","article-title":"Low bone mass is an infrequent feature of the adult growth hormone deficiency syndrome in middle-age adults and the elderly","volume":"89","author":"Murray","year":"2004","journal-title":"J\u00a0Clin Endocrinol Metabol"},{"key":"10.1016\/j.beem.2022.101614_bib90","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1210\/jc.2005-0897","article-title":"A\u00a0densitometric and morphometric analysis of the skeleton in adults with varying degrees of growth hormone deficiency","volume":"91","author":"Murray","year":"2006","journal-title":"J\u00a0Clin Endocrinol Metabol"},{"key":"10.1016\/j.beem.2022.101614_bib91","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/s12020-015-0738-z","article-title":"Incidence of morphometric vertebral fractures in adult patients with growth hormone deficiency","volume":"52","author":"Mazziotti","year":"2016","journal-title":"Endocrine"},{"key":"10.1016\/j.beem.2022.101614_bib92","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1210\/er.2007-0036","article-title":"Growth hormone, insulin-like growth factors, and the skeleton","volume":"29","author":"Giustina","year":"2008","journal-title":"Endocr Rev"},{"key":"10.1016\/j.beem.2022.101614_bib93","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1530\/eje.1.02317","article-title":"Ten-year GH replacement increases bone mineral density in hypopituitary patients with adult onset GH deficiency","volume":"156","author":"G\u00f6therstr\u00f6m","year":"2007","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.beem.2022.101614_bib94","first-page":"2865","article-title":"Two years of growth hormone (GH) treatment increases bone mineral content and density in hypopituitary patients with adult-onset GH deficiency","volume":"81","author":"Johannsson","year":"1996","journal-title":"J\u00a0Clin Endocrinol Metabol"},{"key":"10.1016\/j.beem.2022.101614_bib95","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/S2213-8587(15)00098-4","article-title":"Fracture risk in adult patients treated with growth hormone replacement therapy for growth hormone deficiency: a prospective observational cohort study","volume":"3","author":"Mo","year":"2015","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/j.beem.2022.101614_bib96","doi-asserted-by":"crossref","first-page":"3079","DOI":"10.1210\/jcem.86.7.7669","article-title":"Additional beneficial effects of alendronate in growth hormone (GH)-deficient adults with osteoporosis receiving long-term recombinant human GH replacement therapy: a randomized controlled trial","volume":"86","author":"Biermasz","year":"2001","journal-title":"J\u00a0Clin Endocrinol Metabol"},{"key":"10.1016\/j.beem.2022.101614_bib97","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1111\/j.1365-2265.2004.02021.x","article-title":"Long-term skeletal effects of recombinant human growth hormone (rhGH) alone and rhGH combined with alendronate in GH-deficient adults: a seven-year follow-up study","volume":"60","author":"Biermasz","year":"2004","journal-title":"Clin Endocrinol"},{"key":"10.1016\/j.beem.2022.101614_bib98","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1007\/s12020-021-02751-9","article-title":"Prevalence of vertebral fractures and serum sclerostin levels in acromegaly","volume":"73","author":"Uygur","year":"2021","journal-title":"Endocrine"},{"key":"10.1016\/j.beem.2022.101614_bib99","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1210\/jc.2014-2937","article-title":"Bone turnover, bone mineral density, and fracture risk in acromegaly: a meta-analysis","volume":"100","author":"Mazziotti","year":"2015","journal-title":"J\u00a0Clin Endocrinol Metabol"},{"key":"10.1016\/j.beem.2022.101614_bib100","doi-asserted-by":"crossref","first-page":"2416","DOI":"10.1210\/jc.2016-3693","article-title":"Calcium and bone turnover markers in acromegaly: a prospective, controlled study","volume":"102","author":"Constantin","year":"2017","journal-title":"J\u00a0Clin Endocrinol Metabol"},{"key":"10.1016\/j.beem.2022.101614_bib101","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1530\/EJE-16-0808","article-title":"Bone material strength index as measured by impact microindentation is altered in patients with acromegaly","volume":"176","author":"Malgo","year":"2017","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.beem.2022.101614_bib102","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1007\/s11102-017-0847-1","article-title":"Bone histomorphometry in acromegaly patients with fragility vertebral fractures","volume":"21","author":"Dalle Carbonare","year":"2018","journal-title":"Pituitary"},{"key":"10.1016\/j.beem.2022.101614_bib103","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.bone.2019.04.017","article-title":"Risk factors for fragility fractures in type 1 diabetes","volume":"125","author":"Leanza","year":"2019","journal-title":"Bone"},{"key":"10.1016\/j.beem.2022.101614_bib104","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1002\/jbmr.3826","article-title":"Glycemic control and insulin treatment alter fracture risk in older men with type 2 diabetes mellitus","volume":"34","author":"Lee","year":"2019","journal-title":"J\u00a0Bone Miner Res : The Official Journal of the American Society for Bone and Mineral Research"}],"container-title":["Best Practice &amp; Research Clinical Endocrinology &amp; Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521690X2200001X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521690X2200001X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T16:58:28Z","timestamp":1761497908000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521690X2200001X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3]]},"references-count":104,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022,3]]}},"alternative-id":["S1521690X2200001X"],"URL":"https:\/\/doi.org\/10.1016\/j.beem.2022.101614","relation":{},"ISSN":["1521-690X"],"issn-type":[{"value":"1521-690X","type":"print"}],"subject":[],"published":{"date-parts":[[2022,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Regulation of bone mass in endocrine diseases including diabetes","name":"articletitle","label":"Article Title"},{"value":"Best Practice & Research Clinical Endocrinology & Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.beem.2022.101614","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"101614"}}